Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
Young Onset Parkinson’s Network Joins National Movement Disorders Nonprofit PMD Alliance
Episode 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease
NeurologyLive® Friday 5 — September 13, 2024
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Gene Therapy RGX-121 Demonstrates Promising Results in Pivotal CAMPSIITE Trial of Hunter Syndrome
Protecting Brain Health in High-Intensity Sports With Innovative Helmet